Evaluating Muscle Weakness Improvement With Lorcaserin in ICU
Status:
Terminated
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
ICU acquired muscle weakness is a significant problem in patients recovering from critical
illness. This trial will evaluate the safety and efficacy of a drug in improving muscle
weakness in critically ill patients.